Helix Biopharma Corp. HBPCF
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 303.52% | -98.34% | 117.24% | -93.99% | 0.15% |
| Total Receivables | -11.21% | -21.70% | 7.75% | 123.53% | -63.75% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -51.44% | -58.31% | -1.99% | -30.68% | -18.97% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 203.13% | -93.55% | 66.16% | -71.97% | -10.30% |
|
|
|||||
| Total Current Assets | 203.13% | -93.55% | 66.16% | -71.97% | -10.30% |
| Net Property, Plant & Equipment | -86.27% | -88.71% | -78.46% | -87.50% | -79.35% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 1,936,628.57% | 1,874,485.71% | 1,898,085.71% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2,051.19% | 781.63% | 4,479.33% | 1,160.40% | -12.35% |
|
|
|||||
| Total Accounts Payable | 42.59% | 83.03% | 107.53% | 168.84% | 62.60% |
| Total Accrued Expenses | -74.18% | -56.60% | -26.37% | -20.45% | 68.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 183.22% | 49.32% | 67.78% | 103.29% | 58.55% |
|
|
|||||
| Total Current Liabilities | 183.22% | 49.32% | 67.78% | 103.29% | 58.55% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 183.22% | 49.32% | 67.78% | 103.29% | 58.55% |
|
|
|||||
| Common Stock & APIC | 11.46% | 17.18% | 10.90% | 10.31% | 2.97% |
| Retained Earnings | -3.08% | -8.80% | -1.73% | -2.28% | -4.08% |
| Treasury Stock & Other | -28.83% | -13.42% | -26.55% | -16.85% | 53.70% |
| Total Common Equity | 1,172.78% | 86,548.09% | 1,271.27% | 17,373.01% | -284.08% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1,172.78% | 86,548.09% | 1,271.27% | 17,373.01% | -284.08% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,172.78% | 86,548.09% | 1,271.27% | 17,373.01% | -284.08% |
|
|
|||||